Mucuna pruriens in parkinson's disease: a double-blind, randomized, placebo-controlled, crossover study

被引：0
|
作者：
Cilia, R. [1 ]
Laguna, J. [2 ]
Cassani, E. [1 ]
Cereda, E. [3 ]
Pezzoli, G. [1 ]
机构：
[1] Parkinson Inst, Neurol, Milan, Italy
[2] Clin Nino Jesus, Neurol, Santa Cruz, Bolivia
[3] Fdn IRCCS Policlin San Matteo, Nutr & Dietet Serv, Pavia, Italy
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2015年 / 357卷
关键词：
D O I：
10.1016/j.jns.2015.08.925
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
863
引用
收藏
页码：E262 / E263
页数：2
相关论文
共 50 条
  • [1] Mucuna pruriens therapy in Parkinson's disease: A double-blind, placebo-controlled, randomized, crossover study
    Cilia, R.
    Laguna, J.
    Cassani, E.
    Cereda, E.
    Pezzoli, G.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S425 - S425
  • [2] Mucuna pruriens in Parkinson disease A double-blind, randomized, controlled, crossover study
    Cilia, Roberto
    Laguna, Janeth
    Cassani, Erica
    Cereda, Emanuele
    Pozzi, Nicolo G.
    Isaias, Ioannis U.
    Contin, Manuela
    Barichella, Michela
    Pezzoli, Gianni
    [J]. NEUROLOGY, 2017, 89 (05) : 432 - 438
  • [3] Donepezil for dementia in Parkinson's disease: A randomized, double-blind, placebo-controlled, crossover study.
    Ravina, B
    Putt, M
    Siderowf, A
    Farrar, JT
    Gillespie, M
    Crawley, A
    Fernandez, H
    Treischmann, M
    Reichwein, S
    Simuni, T
    [J]. MOVEMENT DISORDERS, 2004, 19 (09) : 1132 - 1133
  • [4] Mucuna pruriens in Parkinson's disease: A double-blind clinical and pharmacological study
    Katzenschlager, R
    Evans, A
    Manson, A
    Patsalos, P
    Ratnaraj, N
    Lees, AJ
    [J]. MOVEMENT DISORDERS, 2004, 19 : S249 - S249
  • [5] Donepezil treatment in Parkinson's disease with dementia: A double-blind, placebo-controlled crossover study
    Aarsland, D
    Larsen, JP
    Janvin, C
    Laake, K
    [J]. NEUROLOGY, 2001, 56 (08) : A128 - A128
  • [6] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    [J]. MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [7] Rivastigmine in dementia associated with Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Emre, M.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 298 - 298
  • [8] Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study
    Lou, JS
    Kearns, G
    Benice, T
    Oken, B
    Sexton, G
    Nutt, J
    [J]. MOVEMENT DISORDERS, 2003, 18 (10) : 1108 - 1114
  • [9] Helicobacter pylori eradication in Parkinson's disease: A double-blind randomized placebo-controlled study
    Tan, A. H.
    Lim, S. Y.
    Mahadeva, S.
    Loke, M. F.
    Vadivelu, J. S.
    Marras, C.
    Fox, H.
    Lang, A. E.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S422 - S425
  • [10] Atomoxetine for the Treatment of Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
    Weintraub, Daniel
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A67 - A67
12345